Mankind Pharma Ltd share price logo

Mankind Pharma Ltd

₹2665.00

+36.00

(+1.37%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

What are INDmoney investors doing with Mankind Pharma shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Among the most traded stocks

229th

Mankind Pharma was the 229th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

27 days

INDmoney investors hold Mankind Pharma shares for an average of 27 days.

Key Events for Mankind Pharma

Last Dividend Declared

₹1.00 per share, declared on 31/07/2025

View Dividend History

Mankind Pharma Stock Performance

as on November 20, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹2,620.20
    ₹2,669.90
    downward going graph

    1.68%

    Downside

    0.18%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹1,909.70
    ₹2,705.00
    downward going graph

    28.34%

    Downside

    1.50%

    Upside

    downward going graph

Mankind Pharma share price movements today

Previous Close
₹2,629.00
Open
₹2,627.00
Volume
4.56L
Upper Circuit
₹2,734.40
Lower Circuit
₹2,575.20
Day's Low - High
₹2,620.20 - ₹2,669.90
52 Week Low - High
₹1,909.70 - ₹2,705.00

Mankind Pharma Historical Returns

1 Month Return
+ 17.11 %
3 Month Return
+ 12.23 %
1 Year Return
+ 19.9 %
3 Year Return
+ 37.73 %
5 Year Return
+ 87.37 %

Mankind Pharma Fundamentals

as on November 20, 2026 at 4:01 pm IST

Market Cap

₹1,10,076.52 Cr

Return on Equity (ROE)

13.27

PE Ratio (TTM)

49.05

Return on capital employed (ROCE)

13.07

Industry PE ratio

54.13

Beta (LTM)

0.55

P/B Ratio

5.05

Dividend Yield

0.05

PEG Ratio

4.2

Quarterly Earnings Growth YOY

37.67

EPS (TTM)

1938.23

Book Value

16301.46

Mankind Pharma Stock Valuation

as on November 20, 2026 at 4:01 pm IST

Mankind Pharma in the last 5 years

  • Overview

  • Trends

Lowest (40.63x)

August 5, 2024

Today (49.05x)

November 20, 2026

Industry (54.13x)

November 20, 2026

Highest (58.15x)

October 7, 2025

LowHigh

Today’s Price to Earnings Ratio: 49.05x

Mankind Pharma Technical Analysis

Track how Mankind Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish3
Bullish8
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
0.74
Bearish
CCI (20)
23.83
Neutral
RSI (14)
53.74
Neutral
Momentum (10)
0
Neutral
ADI (14)
57.43
Neutral
Ultimate Oscillator (7,14,28)
85.28
Bullish

Moving Averages

Name

Value

Action

SMA (20)
2657.21
Bearish
EMA (20)
2656.61
Bullish
VWMA (20)
2657.16
Bearish
SMA (50)
2654.29
Bullish
EMA (50)
2654.7
Bullish
SMA (200)
2653.65
Bullish
EMA (200)
2651.27
Bullish
KAMA (200)
2654.99
Bullish
DEMA (200)
2655.96
Bullish

Mankind Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mankind Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY1,10,076.5217.47%0.651,93814,277
BUY38,676.9940.45%0.507094,147
BUY44,350.5614.4%0.639419,203
BUY61,994.4511.58%0.602,35314,712
BUY1,03,510.4837.33%0.603,50233,653

Market expectation of Mankind Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

52.63%

Buy

26.32%

Hold

21.05%

Sell

Mankind Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
2,606.95
2,422.24
2,867.85
3,061.43
3,198.79
3,079.37
3,570.35
3,697.16
3,567.2
3,442.93
4,030.59
4,337.86
Other Income
74.73
94.56
107.9
111.63
87.09
253.65
83.05
94.19
75.96
117.28
48.94
98.53
Total Income
2,681.68
2,516.8
2,975.75
3,173.06
3,285.88
3,333.02
3,653.4
3,791.35
3,643.16
3,560.21
4,079.53
4,436.39
Expenses
2,000.45
1,836.27
2,196.29
2,216.61
2,382.8
2,400.52
2,723.58
2,775.83
2,754.36
2,536.21
2,974.4
3,166.61
Operating Profit
606.5
585.97
671.56
844.82
815.99
678.85
846.77
921.33
812.84
906.72
1,056.19
1,171.25
Operating Profit Margin %
23.26%
24.19%
23.42%
27.6%
25.51%
22.05%
23.72%
24.92%
22.79%
26.34%
26.2%
27%
Profit Before Interest, Tax and Depreciation
681.23
680.53
779.46
956.45
903.08
932.5
929.82
1,015.52
888.8
1,024
1,105.13
1,269.78
Interest
9.19
9.17
10.84
7.1
220.93
190.54
170.65
169.68
157.2
141.75
109.98
104.94
Depreciation
109.72
99.78
102.69
100.49
187.17
230.87
218.68
221.82
222.6
223.08
225.7
235.73
Profit Before Tax
562.32
571.58
665.93
848.86
494.98
511.09
540.49
624.02
509
659.17
769.45
929.11
Tax Paid
102.51
94.99
122.86
189.98
110.46
86.44
95.87
103.84
95.12
99.75
195.36
212.99
Profit After Tax
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
413.88
559.42
574.09
716.12
Total Net profit including share of profit / Loss from associate company
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
413.88
559.42
574.09
716.12
EPS
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
13.76
17.23
Actual EPS
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
13.76
17.23
Adjusted EPS
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
13.76
17.23
Diluted EPS
11.31
11.74
13.37
16.28
9.44
10.18
10.6
12.38
9.89
13.41
13.74
17.2

Mankind Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
5,865.23
6,214.43
7,781.56
8,749.43
10,260.44
12,207.44
14,277.64
Other Income
121.96
182.63
210.48
140.99
296.41
553.56
370.48
Total Income
5,987.19
6,397.06
7,992.03
8,890.42
10,556.85
12,761
14,648.12
Expenses
4,428.42
4,566.33
5,792.2
6,848.8
7,746.76
9,189.51
10,789.98
Operating Profit
1,436.81
1,648.1
1,989.36
1,900.63
2,513.68
3,017.93
3,487.66
Operating Profit Margin %
24.5%
26.52%
25.57%
21.72%
24.5%
24.72%
24.43%
Profit Before Interest, Tax and Depreciation
1,558.77
1,830.73
2,199.83
2,041.63
2,810.09
3,571.49
3,858.14
Interest
21.97
20.15
58.61
44.47
32.75
429.41
639.28
Depreciation
99.06
118.97
166.62
325.92
378.42
621.22
886.18
Profit Before Tax
1,437.74
1,691.61
1,974.6
1,671.24
2,398.92
2,520.86
2,332.68
Tax Paid
381.59
398.58
521.64
361.57
457.15
509.74
394.58
Profit After Tax
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
1,938.1
Total Net profit including share of profit / Loss from associate company
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
1,938.1
EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Actual EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Adjusted EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Diluted EPS
26.36
32.28
35.78
32
47.68
49.19
46.28

Mankind Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
1,069.71
1,137.24
919.78
1,813.3
2,152.44
2,413.38
3,121.29
Cash Flow from Investing Activities
-435.54
-1,221.85
-1,368.67
-1,051.82
-2,080.52
-12,624.07
-180.79
Cash Flow from Financing Activities
-530.74
-7.81
604.62
-739.72
5.27
10,232.56
-2,952.69
Net Cash Flow
103.42
-92.4
155.73
21.76
77.19
21.87
-12.19

Mankind Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
76.5%
74.88%
74.87%
74.87%
72.71%
72.7%
72.68%
72.67%
72.66%
72.66%
72.63%
72.62%
DII
9.49%
11.14%
9.95%
9.9%
11.06%
11.48%
11.5%
11.92%
13.25%
14.46%
15.39%
15.56%
FII
0%
9.87%
11.58%
12.37%
13.34%
12.92%
13.07%
12.84%
11.34%
10.24%
9.45%
9.37%
Public
6.97%
4.11%
3.61%
2.86%
2.9%
2.9%
2.75%
2.57%
2.75%
2.64%
2.53%
2.45%
Total Outstanding Shares
40,05,88,440
40,05,88,440
40,06,35,138
40,06,44,138
41,25,66,899
41,25,78,527
41,27,28,748
41,27,58,490
41,28,05,072
41,28,28,328
41,29,95,978
41,30,45,090
Total Shareholders
1,27,449
1,35,116
1,53,450
1,63,854
1,71,281
1,80,597
1,79,549
1,70,347
1,77,539
1,77,606
1,66,715
1,63,770

Mutual Funds Buying / Exiting Mankind Pharma

Holdings as of 15 Nov 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Mankind Pharma

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Nippon India Large Cap Fund - Direct Plan - Growth Plan

Nippon India Large Cap Fund - Direct Plan - Growth Plan

₹602.81 Cr

₹31.89 Cr (+5.59%)

1.08%

Aditya Birla Sun Life Flexi Cap Fund Direct Plan Growth

Aditya Birla Sun Life Flexi Cap Fund Direct Plan Growth

₹559.65 Cr

₹6.91 Cr (+1.25%)

1.84%

Mutual Funds Exiting Mankind Pharma

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Indices Featuring Mankind Pharma Stock

Check stock indices that include Mankind Pharma.

Nifty Healthcare

₹17,474.60

+135.65 (▲0.78%)

S&P BSE 150 MidCap

₹16,738.47

+66.36 (▲0.40%)

Nifty LargeMidcap 250

₹17,049.05

+137.05 (▲0.81%)

Nifty Midcap 50

₹17,885.85

+129.70 (▲0.73%)

NIFTY PHARMA

₹28,386.90

+15.10 (▲0.05%)

S&P BSE 250 LargeMidCap

₹11,234.32

+95.91 (▲0.86%)

BSE 500

₹37,735.95

+292.28 (▲0.78%)

BSE 200

₹11,815.78

+107.65 (▲0.92%)

Nifty Midcap 100

₹62,031.00

+406.60 (▲0.66%)

Nifty 500

₹24,088.80

+191.65 (▲0.80%)

S&P BSE 400 MidSmallCap

₹12,485.01

+36.23 (▲0.29%)

Nifty Midcap 150

₹22,750.80

+136.95 (▲0.61%)

Nifty MidSmallcap 400

₹20,941.20

+75.35 (▲0.36%)

BSE Healthcare

₹53,250.74

+328.84 (▲0.62%)

Nifty 200

₹14,587.75

+135.10 (▲0.93%)

Insights on Mankind Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 3.56K Cr → 4.43K Cr (in ₹), with an average increase of 10.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MANKIND stock has moved up by 17.1%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 10.87% to 11.31% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 408.75 Cr → 711.48 Cr (in ₹), with an average increase of 16.3% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.63% to 72.62% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 2.53% to 2.45% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 9.45% to 9.37% in Sep 2026 quarter

Mankind Pharma Stock Futures & Options Contracts

View the latest movement in Mankind Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Mankind Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 23 Nov ₹2700 Call
November 23, 2026
₹2700
₹7.3
-0.55
-7.01%
MANKIND 23 Nov ₹2660 Call
November 23, 2026
₹2660
₹16
0.4
2.56%
MANKIND 23 Nov ₹2640 Call
November 23, 2026
₹2640
₹24.55
1.25
5.36%
MANKIND 23 Nov ₹2740 Call
November 23, 2026
₹2740
₹6.2
2.7
77.14%

Mankind Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 23 Nov Fut
November 23, 2026
-
₹2638.4
2.37
0.09%
MANKIND 29 Dec Fut
December 29, 2026
-
₹2669.4
13.81
0.52%
MANKIND 25 Jan Fut
January 25, 2027
-
₹2690
25.58
0.96%

About Mankind Pharma Ltd

Mankind Pharma Ltd. was established in 1991 as a Private Limited Company. In 2005 it was converted to a Public Limited Company and the name changed to Mankind Pharma Limited. The Company is engaged in the development, manufacturing and marketing of a range of pharmaceuticals and consumer healthcare products, and is active in acute and chronic therapeutic areas such as anti-infectives, cardiovascular and gastrointestinal treatments, antidiabetic and neuro/CNS medicines, vitamins, minerals and nutrients. In 2004, they entered the chronic pharmaceutical segment, and have added further products over the years, including ophthalmic products, consumer healthcare products, animal healthcare products and specialty therapeutic divisions. They operate 23 manufacturing facilities across India and had 2181 manufacturing personnel as of March 31, 2021. It is now planning to raise capital through the public offering of 40058844 equity shares, with a total installed capacity of 40.77 billion units across a range of products.

Revenue: ₹4,337.86Cr as on September 2026 (Q2 FY27)
Net Profit: ₹716.12Cr as on September 2026 (Q2 FY27)
Listing date: 09 May, 2023
Chairperson Name: RAMESH CHAND JUNEJA
OrganisationMankind Pharma Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
CEORAMESH CHAND JUNEJA
E-voting on sharesClick here to vote

FAQs

What is Mankind Pharma share price today?

Mankind Pharma share price today stands at ₹2665 as on at the close of the market. Mankind Pharma share today touched a day high of ₹2669.9 and a low of ₹2620.2.

What is the 52 week high and 52 week low range for Mankind Pharma share?

Mankind Pharma touched a 52 week high of ₹2705 and a 52 week low of ₹1909.7. Mankind Pharma share price today i.e. is closed at ₹2665, which is -1.48% down from its 52 week high and 39.55% up from its 52 week low.

What is Mankind Pharma's market capitalisation today?

Mankind Pharma market capitalisation is ₹1,10,076.52 Cr as on .

How to buy Mankind Pharma shares?

To buy Mankind Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MANKIND or Mankind Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Mankind Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Mankind Pharma trading volume today?

Mankind Pharma trading volume is 4.56L as on . This means that 4.56L shares of Mankind Pharma were bought and sold on the stock market during today's trading session.